Blueprint Medicines to Present at Upcoming Investor Conferences in February
Guggenheim Healthcare Talks Idea Forum| Oncology Day in New York, NYon Thursday, February 14, 2019at 11:30 a.m. ET.
- 8th Annual
SVB Leerink Partners Global Healthcare Conferencein New York, NYon Wednesday, February 27, 2019at 1:00 p.m. ET.
A live webcast of each presentation will be available by visiting the Investors & Media section of Blueprint Medicines' website at http://ir.blueprintmedicines.com. A replay of the webcasts will be archived on Blueprint Medicines' website for 30 days following each presentation.
Blueprint Medicines is a precision therapy company striving to improve human health. With a focus on genomically defined cancers, rare diseases and cancer immunotherapy, we are developing transformational medicines rooted in our leading expertise in protein kinases, which are proven drivers of disease. Our uniquely targeted, scalable approach empowers the rapid design and development of new treatments and increases the likelihood of clinical success. We are currently advancing four investigational medicines in clinical development, along with multiple research programs. For more information, visit www.BlueprintMedicines.com and follow us on Twitter (@BlueprintMeds) and LinkedIn.
View original content to download multimedia:http://www.prnewswire.com/news-releases/blueprint-medicines-to-present-at-upcoming-investor-conferences-in-february-300785770.html
Jim Baker, 617-844-8236, JBaker@blueprintmedicines.com